AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Obesity Cohort : Medical Follow-up of Severe or Morbid Obese Patients Undergoing Bariatric Surgery

RecruitingNAAges 15 Years - anyAllUniversity Hospital, Montpellier
💬

In plain words

What the trial is, and whether it could suit you

The aim of this cohort is to evaluate the follow-up of morbidly obese patients treated by several types of bariatric procedures. In addition, this study could lead to the development of clinical trials on assessment of the bariatric surgery impact.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Only be considered in patients operated and followed at CHU Montpellier with bariatric surgery * Patients treated by bariatric surgery on CHU Montpellier * Agreed to participate to the study by signing an informed consent * Eligible to health insurance Exclusion Criteria: * Unable to follow the patient in the long term (foreign patients, surgical use ...) * Inability to follow in the long run
💊

What it tests

  • Bariatric surgery
📍

Where

1 site
CHRU - Hôpital Saint Eloi
Montpellier, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy